Assistant Professor, Radiation Oncology Albert Einstein College of Medicine (July 1985 – June 2001)
Associate Professor, Radiation Oncology Albert Einstein College of Medicine (July 2001 – Mar 2003)

Attending Physician, Radiation Oncology, University of Washington, WA, 1983 – 1984
Attending Physician, Radiation Oncology, Montefiore Medical Center, NY, 1984 – 2003
Attending Physician, Radiation Oncology, North Shore University Hospital, NY, 2003 – 2010
Attending Physician, Radiation Oncology, Long Island Jewish, NY, 2003 – 2010
Director, Radiation Oncology, Glen Cove Hospital, NY, 2004 – 2010
Bronx Lebanon Hospital NY, 2010 – 2015
St. John’s Hospital, NY, 2010 – 2018
St. Joseph’s Hospital, NY, 2014 – 2017
Northern Westchester Hospital, NY, 2010 – Present
Lawrence Hospital, NY, 2010 – 2017
Mt. Vernon Hospital, NY, 2010 – Present
Nassau University Medical Center, NY, 2016 – 2017
Phelps Hospital, NY, 2017
Lenox Hill Hospital, NY, 2017
Mount Sinai West, NY, 2017 – Present

1. Cooper, J. S., DelRowe, J., and Newall, J.
Regional Stage IV Carcinoma of the Nasopharynx Treated by Aggressive Radiotherapy Int. J. Rad. One., Biol., Phys Nov. 9(11) 1737-45, 1983

2. Pelton, J. G., Del Rowe, J., Bolen, J.W., Russell, A.H., Laramore, G.E., Griffin, T.W., Griffin, B. R. Fast Neutron Radiotherapy for Soft Tissue Sarcomas
Am J. Clinical Oncology 9(5) 397 400, 1986

3. Scott, R., Del Rowe, J.
A Transient Hypotensive (Jarrod-BezheJd) Effect in a Patient Treated with Microwave Hyperthermia Am. J. Clinical Oncology 9(2):170-172, 1986.

4. Goldstein, J., Becker, N., Del Rowe, J., Davis, L.
Cutaneous T-Cell Lymphoma in a Patient Infected with Human Immunodeficiency Virus Type 1 Cancer Vol. 66 No.6, pg1130-2, September 1990

5. Welch, W., Oestreich, H., Del Rowe, J., Hirschfeld, A., Kao, M, Michelsen, W. Jost Radiosurgery: A Non-invasive Method to Treat Lesions within the Brain
Einstein Quarterly J. Biol. Med: vol 1: 2-6; 1993

6. Urtasun, R.C., Cosmatos, D., Del Rowe, J., Kinsella, T. J., Lester, S., Wasserman, T., Fulton, D.S. Idoxuridine (IUdR) Combined with Radiation in the treatment of Malignant Glioma:
A Comparison of Short vs. Long Intravenous Dose Schedules (RTOG 86-12)
Int. J. Rad. One. Biol. Physics, 27 Number 2 pp 207-215 September 30, 1993

7. Marvel, C., Del Rowe, J., Bremer, E., Moskal, J. Altered RNA Turnover in Carcinogenesis
J. Chem. Mol. Neuropath. 21: 353-368; 1994

8. Mun, C., Del Rowe, J., Sandigursky, M., Minton, K., Franklin, W.
DNA Deoxyribophosphodiesterase and an Activity that Cleaves DNA Containing Thymine glycol Adducts in Deinococcus Radiodurans
Radiation Research vol. 138: 282-285; 1994

9. Watkins-Bruner, D., Scott, C., Lawton, C., Del Rowe, J., Rotman, M., Buswell, L., Beard, C., Cella, D.
RTOG’s First Quality of Life Study-RTOG 90-20 A Phase II Trial of External Beam Radiation with Etanidazole for the Treatment of Locally Advanced Prostate Cancer Int. J. Rad. One. Biol. Physics: vol. 33 no. 4: 901-906, 1995

10. Ahmed, M., Fontenla, D.P., Lai, P.P., Del Rowe, J., Yaparpalvi, R., Deare, S.M., Curran, J., Wojcicka, J., Vikram, B.
Three Dimensional External-Beam Radiation Treatment Planning and Real-Time Dose
Verification of Pituitary Adenoma: Clinical and Physical Considerations Radiation Oncology Investigations 3; 141-148 (1995)

11. Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Bahary, J.P., Kline, R., Wharam, M., Schultz, C., Davey, P., Loeffler, J., Del Rowe, J., Marks, L., Fisher, B., Shin, K. Radiosurgery for Previously Irradiated Primary Brain Tumors and Brain Metastases: Initial Analysis of Radiation Therapy Oncology Group Protocol 9005
Int. J. Rad. One. Biol. Physics vol. 34 no. 3: 647-54, 1996

12. Emami, B., Scott, C., Perez, C., Asbell, S., Swift, P., Grigsby, P., Montesano, A., Rubin, P., Curran., Del Rowe, J., Arastu, H., Fu, K., Moros, E.
Phase III study of Interstitial Thermoradiotherapy Compared with Interstitial Radiotherapy Alone in the Treatment of Recurrent Or Persistent Human Tumors: A Prospectively Controlled Randomized Study by the RTOG
Int. J. Rad.One. Biol. Physics 34 no. 5: 1097-1104, 1996

13. Scarantino, C.W., Caplan R., Rotman M., Coughlin C., Demas W., Del Rowe, J.
A phase I/II study to evaluate the effect of fractionated hemi-body irradiation in the treatment of osseous metastases–RTOG 88-22
Int J Rad. One. Biol Phys 1996 Aug 1; 36(1):37-48

14. Lawton C.A., Coleman C.N., Buzydlowski J.W., Forman J.D., Marcial V.A., DelRowe J., Rotman M.
Results of a phase II trial of external beam radiation with etanidazole (SR2508) for the Treatment of locally advanced prostate cancer (RTOG Protocol 90-20):
Int J Rad. One. Biol Phys 1996 Oct 1; 36(3):673-80

15. Urtasun, R., Kinsella, T., Farnan, N., Del Rowe, J., Lester, S., Fulton, D.
Survival Improvement in Anaplastic Astrocytoma combining External Radiation with Halogenated Pyrimidines Final Report of RTOG 86-12, Phase 1-11 Study
Int. J. Rad. One. Biol, Phys. 36 No. 5 pp 1163-1167 1996

16. Lawton, C.A., Winter, K., Byhardt, R., Sause, W., Hanks, G., Russell, A. H., Rotman, M., Porter, A., McGowan, D., Del Rowe, J., Pilepich, M.
Androgen Suppression plus Radiation vs. Radiation Alone for Patients with Dl (pN+) Adenocarcinoma of the Prostate (Results Based on a National Prospective Randomized Trial RTOG 85-31)
Int. J. Rad. One. Biol Phys. 1997 Jul 15; 38 (5)931-9

17. Del Rowe, J.D., Bello, J., Mitnick, R., Sood, B., Filippi, C., Moran, J., Freeman, K., Mendez, F., Bases R.
Accelerated regression of brain metastases in patients receiving whole brain radiation and the Topoisomerase II inhibitor, lucanthone
Int J Rad One Biol Phys 1999 Jan 1; 43(1):89-93

18. Streeter, O.E. Jr, Martz, K.L., Gaspar, L.E., Del Rowe, J.D., Asbell, S.O., Salter, M.M., Roach M. Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01
Int J Rad. One. Biol Phys 1999 Jul 15; 44(5):1047-52

19. Del Rowe, J., Scott, C., Werner-Wasik, M., Bahary, J.P., Curran, W.J., Urtasun, R.C., Fisher B. Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme
J. Clinical Oncology Mar 13, 2000: 1254-59

20. Casper, D., Lekhraj, R., Yaparpalvi, U.S., Pidel, A., Jaggernauth, W.A., Werner, P., Tribius, S. , Del Rowe J., LaSala, P.A.
Acetaminophen selectively reduces glioma cell growth and increases radiosensitivity in culture
J. Neurooncol. 2000; 46(3):215-29.

21. Garg M.K., Weiss P., Sharma A.K., Gorla G.R., Jaggernauth W., Yaparpalvi R., Del Rowe J., Beitler J.J.
Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have
recurred after surgical excision and external radiation Radioth er Oncol. 2004 Nov; 73(2):233-6

Gejerman, G, Del Rowe, J, Vikram B: Prophylactic Cranial Irradiation to Prevent Fatal Cerebral Leukostasis: Proceedings of the 35th Annual ASTRO Meeting
Int. J. of Rad One Biol Physics Vol 27, Supplement 1 Abstract Number 1114 pg 313, October 1993

Emami, B, Scott, C, Perez, C, Asbell, S, Swift, P, Grigsby, P, Monstesna, A, Rubin, P, Curran, W, Del Rowe, J, Arastu, H, Fu, K, Moros, E: Phase III Study of Interstitial Thermoradiotherapy Compared with Interstitial Radiotherapy alone in the Treatment of Recurrent Or Persistent Human Tumors: A Prospectively Controlled Randomized Study By The Radiation Therapy Oncology Group Proceedings of the 35th Annual ASTRO Meeting
Int. J. of Rad One Biol Physics: Vol. 27, Supplement 1 Number47, pg 155 October 1993

Hutchinson, R, Krailo, M, Fryer C, Daview PC, Nachman, J, Reardon, D, Collins, R, Del Rowe, J, Whalen,T, Blair, G, O’Brien, R, Hays, D, Gyepes, M, Trigg, M, Hammond, D, Meadows, A.: Prognostic Factor Analysis in Advanced Hodgkin’s Disease (States III and IV):Results of the CCG-521 Trial.
International Society of Pediatric Oncology (SIOP) XXVth Meeting San Francisco, October 5 -9, 1993

Franklin, WA, Sandigursky, M, Vinokur, A, and Del Rowe, J: The Role of DNA Deoxyribophosphodiesterase in the Base Excision Repair Pathway. Ninth International Congress of Radiation Research Toronto, Ontario, Canada (1991)

Cooper, JS, Del Rowe, J, Newall, J: An Analysis of Regional Stage IV Carcinoma of the Nasopharynx Treated by Aggressive Radiotherapy. Proc. American Radium Society’s 65th Annual Meeting Savannah, Georgia, April 1983. Am. J. Clio. One: Cancer Clinical Trials 6, 149, 1983

Urtasun, RC, Kinsella, TJ, Del Rowe, J, Farnan, N, Lester, S, Fulton, OS.: Survival Improvement In Anaplastic Astrocytoma Combining External Radiation With Halogenated Pyrimidines.Final Report Of RTOG 86-12, Phase-II Study ASTRO

Submitted Abstracts:

Lawton, CA, Coleman , CN, Buzydlowski, JW, Forman, J.D., Marcial, VA, Del Rowe, J. D., Rotman, M.: Results Of A Phase II Trial Of External Beam Irradiation With Etanidazole (SR-2508) For The Treatment Of Locally Advanced Prostate Cancer (Results Of RTOG Protocol 90-20) ASTRO

Shaw, E, Scott, C, Souhami, L, Dinapoli, R, Bahary, JP, Kline, R, Wharam, M, Schultz, C, Davey, P, Loeffler, J, Del Rowe, J, Marks, L, Fisher, B, Shin, K: Radiosurgery for Previously Irradiated Primary BrainTumors and Brain Metastases: Initial Analysis of Radiation Therapy Oncology Group Protocol 9005 ASTRO

Watkins-Bruner, D, Scott, C, Lawton, C, Del Rowe, J, Rotman, M, Buswell, L, Beard, C, Cella, D The RTOG’s First Completed Quality of Life Study-Lessons Learned ASTRO

Albert Schweitzer Institute for the Humanities, Lecturer; Nijny Novgorod, Russia (October, 1996) ASTRO October, 1989 Pseudouridine as a Tumor Marker for High-Grade Gliomas
ASTRO October, 1984 High LET Radiotherapy in the Treatment of Osteosarcoma

Oncology Grand Rounds, Montefiore Medical Center 1986; Nasopharyngeal Cancer: The Role of Aggressive Radiation Therapy

Seminar Lecturer, Montefiore Medical Center, “I Can Cope”